(NPR) Early Oxford-AstraZeneca Coronavirus Vaccine Data 'Encouraging, ' Scientists Say

Early Oxford-AstraZeneca Coronavirus Vaccine Data 'Encouraging,' Scientists Say








An experimental vaccine candidate being developed by AstraZeneca and Oxford University to protect against COVID-19 triggered an immune response against the coronavirus and appeared to be safe.



Paul Ellis/AFP via Getty Images


hide caption





toggle caption




Paul Ellis/AFP via Getty Images











Early Oxford-AstraZeneca Coronavirus Vaccine Data 'Encouraging,' Scientists Say






Testing in more than 1,000 people found the vaccine spurred an immune response and had no severe side effects. Larger trials are underway.








Loading...